Specific Antiviral Drugs For COVID 19 Market Report 2026
Download Free Sample Buy Now
Specific Antiviral Drugs For COVID 19 Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Specific Antiviral Drugs For COVID 19 Market Report 2026

Global Outlook – By Type (Tablet, Injection), By Indication (Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment), By Drug Class (Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies), By Route Of Administration (Oral, Intravenous, Subcutaneous, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Specific Antiviral Drugs For COVID 19 Market Overview

• Specific Antiviral Drugs For COVID 19 market size has reached to $15.23 billion in 2025

• Expected to grow to $33.17 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%

• Growth Driver: Rise In COVID-19 Cases The Growth Of The Market Due To Increasing Demand For Antiviral Treatments

• Market Trend: Oral Antiviral Innovations Enhance COVID-19 Treatment Accessibility And Effectiveness

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Specific Antiviral Drugs For COVID 19 Market?

Specific antiviral drugs for COVID-19 are medications designed to directly target and inhibit the replication or function of the SARS-CoV-2 virus, which causes COVID-19. These drugs help reduce the severity and duration of the infection by interfering with viral processes such as entry, replication, or assembly.

The main types of specific antiviral drugs for COVID-19 come in tablet and injection forms. Tablets are solid pharmaceutical dosage forms that contain a precise amount of active medicinal ingredient(s) along with excipients, compressed into a small, usually flat or oval shape. These antiviral drugs are indicated for use in hospitalized patients, non-hospitalized patients, and for preventive treatment. The drug classes include nucleoside analogues, protease inhibitors, RNA polymerase inhibitors, entry inhibitors, and monoclonal antibodies, and they are administered via various routes such as oral, intravenous, subcutaneous, and inhalation. These medications are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and other outlets.

Specific Antiviral Drugs For COVID 19 Market Global Report 2026 Market Report bar graph

What Is The Specific Antiviral Drugs For COVID 19 Market Size and Share 2026?

The specific antiviral drugs for covid 19 market size has grown rapidly in recent years. It will grow from $15.23 billion in 2025 to $17.83 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to rapid spread of covid-19, emergency use authorizations, reliance on traditional antiviral drug classes, limited global production capacity, high hospitalization rates.

What Is The Specific Antiviral Drugs For COVID 19 Market Growth Forecast?

The specific antiviral drugs for covid 19 market size is expected to see rapid growth in the next few years. It will grow to $33.17 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to development of next-generation antiviral drugs, increased public-private partnerships, rising preventive treatment adoption, expansion of combination therapies, integration of personalized medicine approaches. Major trends in the forecast period include rising investment in covid-19 antiviral drug development, increasing adoption of oral antiviral tablets, growth in monoclonal antibody therapies, expansion of hospital and retail distribution channels, focus on targeted treatment for hospitalized and high-risk patients.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Specific Antiviral Drugs For COVID 19 Market Segmentation

1) By Type: Tablet, Injection

2) By Indication: Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment

3) By Drug Class: Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies

4) By Route Of Administration: Oral, Intravenous, Subcutaneous, Inhalation

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Tablet: Oral Antiviral Tablets, Combination Antiviral Tablets, Extended-Release Tablets

2) By Injection: Intravenous (IV) Antiviral Injections, Intramuscular (IM) Antiviral Injections, Subcutaneous Antiviral Injections

What Is The Driver Of The Specific Antiviral Drugs For COVID 19 Market?

The rising number of COVID-19 cases is expected to propel the growth of the specific antiviral drugs for the COVID-19 market going forward. COVID-19 cases refer to individuals who tested positive for the SARS-CoV-2 virus, which causes COVID-19. The rising number of COVID-19 cases is due to the emergence of new variants that spread more easily and can partially evade immunity from vaccines or past infections. Specific antiviral drugs for COVID-19 help reduce the severity and duration of the illness, improving patient outcomes and lowering the overall burden of COVID-19 cases. For instance, in May 2025, according to the World Health Organization, a Switzerland-based global public health agency, reported that the Eastern Mediterranean region's test positivity rate jumped from 4% to 17% in early 2025, surpassing the same period in 2024. Therefore, the rising number of COVID-19 cases drives the growth of the specific antiviral drugs for the COVID-19 market.

Key Players In The Global Specific Antiviral Drugs For COVID 19 Market

Major companies operating in the specific antiviral drugs for covid 19 market are Pfizer Inc., Merck & Co. Inc., Gilead Sciences Inc., Shionogi & Co. Ltd., Cipla Limited, Hetero Drugs Limited, Roche Holding AG, Johnson & Johnson, Novartis AG, GSK plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Limited, Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Synairgen plc, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Lupin Limited, Natco Pharma Ltd., Zydus Lifesciences Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Apotex Inc., Mylan N.V.

Global Specific Antiviral Drugs For COVID 19 Market Trends and Insights

Major companies operating in the specific antiviral drugs for the COVID-19 market are focusing on developing innovative therapies, such as oral antiviral therapies, to enhance treatment accessibility and effectiveness. Oral antiviral therapies are medications taken by mouth to inhibit the replication of viruses like COVID-19, offering a convenient and effective treatment option. For instance, in March 2024, Shionogi And Co., a Japan-based pharmaceutical company, launched Xocova and obtained full standard approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for the antiviral drug ensitrelvir. Additionally, it also offers post-exposure prophylaxis by significantly reducing the risk of developing symptomatic COVID-19 in exposed individuals and shortens symptom duration with a favorable safety profile.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Specific Antiviral Drugs For COVID 19 Market?

In July 2024, GSK plc, a UK-based pharmaceutical company, collaborated with CureVac to develop and commercialize next-generation mRNA vaccines for COVID-19 and influenza. This collaboration aims to develop and commercialize innovative mRNA vaccines for influenza and COVID-19 to improve global public health outcomes. CureVac N.V. is a Germany-based company that develops therapies based on messenger RNA (mRNA) technology.

Regional Insights

North America was the largest region in the specific antiviral drugs for COVID 19 market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Specific Antiviral Drugs For COVID 19 Market?

The specific antiviral drugs for COVID-19 market consists of sales of host-directed antivirals, immunomodulators, fusion inhibitors, helicase inhibitors, and tmprss2 inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Specific Antiviral Drugs For COVID 19 Market Report 2026?

The specific antiviral drugs for covid 19 market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the specific antiviral drugs for covid 19 industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Specific Antiviral Drugs For COVID 19 Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $17.83 billion
Revenue Forecast In 2035 $33.17 billion
Growth Rate CAGR of 17.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Indication, Drug Class, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., Gilead Sciences Inc., Shionogi & Co. Ltd., Cipla Limited, Hetero Drugs Limited, Roche Holding AG, Johnson & Johnson, Novartis AG, GSK plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Specific Antiviral Drugs For COVID 19 Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Specific Antiviral Drugs For COVID 19 Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Specific Antiviral Drugs For COVID 19 Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Specific Antiviral Drugs For COVID 19 Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Investment In COVID-19 Antiviral Drug Development

4.2.2 Increasing Adoption Of Oral Antiviral Tablets

4.2.3 Growth In Monoclonal Antibody Therapies

4.2.4 Expansion Of Hospital And Retail Distribution Channels

4.2.5 Focus On Targeted Treatment For Hospitalized And High-Risk Patients

5. Specific Antiviral Drugs For COVID 19 Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Healthcare Clinics

5.4 Government Health Programs

5.5 Contract Research Organizations (CROs)

6. Specific Antiviral Drugs For COVID 19 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Specific Antiviral Drugs For COVID 19 Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Specific Antiviral Drugs For COVID 19 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Specific Antiviral Drugs For COVID 19 Market Size, Comparisons And Growth Rate Analysis

7.3. Global Specific Antiviral Drugs For COVID 19 Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Specific Antiviral Drugs For COVID 19 Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Specific Antiviral Drugs For COVID 19 Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Specific Antiviral Drugs For COVID 19 Market Segmentation

9.1. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablet, Injection

9.2. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment

9.3. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies

9.4. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous, Inhalation

9.5. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

9.6. Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Antiviral Tablets, Combination Antiviral Tablets, Extended-Release Tablets

9.7. Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous (IV) Antiviral Injections, Intramuscular (IM) Antiviral Injections, Subcutaneous Antiviral Injections

10. Specific Antiviral Drugs For COVID 19 Market Regional And Country Analysis

10.1. Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market

11.1. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Specific Antiviral Drugs For COVID 19 Market

12.1. China Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Specific Antiviral Drugs For COVID 19 Market

13.1. India Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Specific Antiviral Drugs For COVID 19 Market

14.1. Japan Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Specific Antiviral Drugs For COVID 19 Market

15.1. Australia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Specific Antiviral Drugs For COVID 19 Market

16.1. Indonesia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Specific Antiviral Drugs For COVID 19 Market

17.1. South Korea Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Specific Antiviral Drugs For COVID 19 Market

18.1. Taiwan Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Specific Antiviral Drugs For COVID 19 Market

19.1. South East Asia Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Specific Antiviral Drugs For COVID 19 Market

20.1. Western Europe Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Specific Antiviral Drugs For COVID 19 Market

21.1. UK Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Specific Antiviral Drugs For COVID 19 Market

22.1. Germany Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Specific Antiviral Drugs For COVID 19 Market

23.1. France Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Specific Antiviral Drugs For COVID 19 Market

24.1. Italy Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Specific Antiviral Drugs For COVID 19 Market

25.1. Spain Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Specific Antiviral Drugs For COVID 19 Market

26.1. Eastern Europe Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Specific Antiviral Drugs For COVID 19 Market

27.1. Russia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Specific Antiviral Drugs For COVID 19 Market

28.1. North America Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Specific Antiviral Drugs For COVID 19 Market

29.1. USA Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Specific Antiviral Drugs For COVID 19 Market

30.1. Canada Specific Antiviral Drugs For COVID 19 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Specific Antiviral Drugs For COVID 19 Market

31.1. South America Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Specific Antiviral Drugs For COVID 19 Market

32.1. Brazil Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Specific Antiviral Drugs For COVID 19 Market

33.1. Middle East Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Specific Antiviral Drugs For COVID 19 Market

34.1. Africa Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Segmentation By Indication, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Specific Antiviral Drugs For COVID 19 Market Regulatory and Investment Landscape

36. Specific Antiviral Drugs For COVID 19 Market Competitive Landscape And Company Profiles

36.1. Specific Antiviral Drugs For COVID 19 Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Specific Antiviral Drugs For COVID 19 Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Specific Antiviral Drugs For COVID 19 Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Shionogi & Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis

37. Specific Antiviral Drugs For COVID 19 Market Other Major And Innovative Companies

Hetero Drugs Limited, Roche Holding AG, Johnson & Johnson, Novartis AG, GSK plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Limited, Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Synairgen plc, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd.

38. Global Specific Antiviral Drugs For COVID 19 Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Specific Antiviral Drugs For COVID 19 Market

40. Specific Antiviral Drugs For COVID 19 Market High Potential Countries, Segments and Strategies

40.1 Specific Antiviral Drugs For COVID 19 Market In 2030 - Countries Offering Most New Opportunities

40.2 Specific Antiviral Drugs For COVID 19 Market In 2030 - Segments Offering Most New Opportunities

40.3 Specific Antiviral Drugs For COVID 19 Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Specific Antiviral Drugs For COVID 19 Market, Overview Of Key Products - Product Examples
  • Table 2: Global Specific Antiviral Drugs For COVID 19 Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Specific Antiviral Drugs For COVID 19 Market, Supply Chain Analysis
  • Table 4: Global Specific Antiviral Drugs For COVID 19 Market, Major Raw Material Providers
  • Table 5: Global Specific Antiviral Drugs For COVID 19 Market, Major Resource Providers
  • Table 6: Global Specific Antiviral Drugs For COVID 19 Market, Major Manufacturers (Suppliers)
  • Table 7: Global Specific Antiviral Drugs For COVID 19 Market, Major Distributors And Channel Partners
  • Table 8: Global Specific Antiviral Drugs For COVID 19 Market, Key Technologies & Future Trends
  • Table 9: Global Specific Antiviral Drugs For COVID 19 Market, Major Trends
  • Table 10: Global Specific Antiviral Drugs For COVID 19 Market, Major End Users
  • Table 11: Global Specific Antiviral Drugs For COVID 19 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Specific Antiviral Drugs For COVID 19 Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Specific Antiviral Drugs For COVID 19 Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Specific Antiviral Drugs For COVID 19 Market - TAM, US$ Billion, 2025
  • Table 15: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Specific Antiviral Drugs For COVID 19 Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Specific Antiviral Drugs For COVID 19 Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: Gilead Sciences Inc. Financial Performance
  • Table 101: Shionogi & Co. Ltd. Financial Performance
  • Table 102: Cipla Limited Financial Performance
  • Table 103: Global Specific Antiviral Drugs For COVID 19 Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Specific Antiviral Drugs For COVID 19 Market, Competitive Dashboard
  • Table 105: Global Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 108: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

List Of Figures

    Figure 1: Global Specific Antiviral Drugs For COVID 19 Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Specific Antiviral Drugs For COVID 19 Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Specific Antiviral Drugs For COVID 19 Market, Supply Chain Analysis
  • Figure 4: Global Specific Antiviral Drugs For COVID 19 Market, Major Raw Material Providers
  • Figure 5: Global Specific Antiviral Drugs For COVID 19 Market, Major Resource Providers
  • Figure 6: Global Specific Antiviral Drugs For COVID 19 Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Specific Antiviral Drugs For COVID 19 Market, Major Distributors And Channel Partners
  • Figure 8: Global Specific Antiviral Drugs For COVID 19 Market, Key Technologies & Future Trends
  • Figure 9: Global Specific Antiviral Drugs For COVID 19 Market, Major Trends
  • Figure 10: Global Specific Antiviral Drugs For COVID 19 Market, Major End Users
  • Figure 11: Global Specific Antiviral Drugs For COVID 19 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Specific Antiviral Drugs For COVID 19 Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Specific Antiviral Drugs For COVID 19 Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Specific Antiviral Drugs For COVID 19 Market - TAM, US$ Billion, 2025
  • Figure 15: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Specific Antiviral Drugs For COVID 19 Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Specific Antiviral Drugs For COVID 19 Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: Gilead Sciences Inc. Financial Performance
  • Figure 101: Shionogi & Co. Ltd. Financial Performance
  • Figure 102: Cipla Limited Financial Performance
  • Figure 103: Global Specific Antiviral Drugs For COVID 19 Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Specific Antiviral Drugs For COVID 19 Market, Competitive Dashboard
  • Figure 105: Global Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 108: Global, Specific Antiviral Drugs For COVID 19 Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes),...

The Antiviral & Antimicrobial Coatings Market Report 2026 - Global Outlook – By Type (Antimicrobial Coatings, Antiviral Coatings), By Material (Silver, Organic Materials, Copper), By Form (Liquid, Powder), By Application...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Breast Cancer Drugs Market Report 2026 - Global Outlook – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Othe...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cance...

Drugs For Hormonal Replacement Therapy Market Report 2026 - Global Outlook – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replac...

Bladder Cancer Drugs Market Report 2026 - Global Outlook – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hosp...

Blood Cancer Drugs Market Report 2026 - Global Outlook – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), ...

Frequently Asked Questions

The Specific Antiviral Drugs For COVID 19 market was valued at $15.23 billion in 2025, increased to $17.83 billion in 2026, and is projected to reach $33.17 billion by 2030.

The global Specific Antiviral Drugs For COVID 19 market is expected to grow at a CAGR of 16.8% from 2026 to 2035 to reach $33.17 billion by 2035.

Some Key Players in the Specific Antiviral Drugs For COVID 19 market Include, Pfizer Inc., Merck & Co. Inc., Gilead Sciences Inc., Shionogi & Co. Ltd., Cipla Limited, Hetero Drugs Limited, Roche Holding AG, Johnson & Johnson, Novartis AG, GSK plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Limited, Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Synairgen plc, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Lupin Limited, Natco Pharma Ltd., Zydus Lifesciences Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Apotex Inc., Mylan N.V. .

Major trend in this market includes: Oral Antiviral Innovations Enhance COVID-19 Treatment Accessibility And Effectiveness. For further insights on this market. request a sample here

North America was the largest region in the specific antiviral drugs for COVID 19 market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specific antiviral drugs for covid 19 market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us